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CXC chemokine release can be modulated by Th2-derived cytokines. Interleukin(IL)-4 is one of the cytokines that are the hall-
mark of the Th-2 response, and plays an important role in human tuberculosis. In the current study, we investigated the ef-
fect of IL-4 on chemokine production by human epithelial cells infected with Mycobacterium bovis bacillus calmette-gu´ erin
(BCG). Gene expression of CXCL-8 and CXCL-10 was determined by the reverse transcription (RT)-polymerase chain reac-
tion method. The levels of immunoreactive CXCL-8 and CXCL-10 were determined by enzyme-linked immunosorbent assay.
We found that, although M. bovis BCG induced gene expression of CXCL-8 and CXCL-10 in M. bovis BCG-infected human
epithelial cells, CXCL-8 mRNA level was signiﬁcantly reduced by IL-4, whereas no signiﬁcant eﬀect of IL-4 was observed on
CXCL10 mRNA level. In addition, IL-4 decreased CXCL-8 (in a graded and signiﬁcant manner) but not CXCL-10 secretion.
These results were further conﬁrmed, since a signiﬁcant reversion was obtained with a neutralizing antibody to human IL-4,
whereas an isotype-matched control antibody had no signiﬁcant eﬀect on CXCL-8 secretion. Furthermore, we found a simi-
lar eﬀect of IL-4 on M. bovis BCG-induced CXCL-8 and CXCL-10 secretion by using other human epithelial A549 cell line.
Collectively, these data demonstrate that M. bovis BCG-infected human epithelial cells can have an active role in a local in-
ﬂammatory immune response via the secretion of CXC chemokines which can be selectively regulated by Th2-derived cy-
tokines.
Copyright © 2006 Patricia M´ endez-Samperio et al. This is an open access article distributed under the Creative Commons
Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is
properly cited.
INTRODUCTION
ThehallmarkofMycobacteriumtuberculosisinfectionischar-
acterized by an inﬂammatory response culminating in the
f o r m a t i o no fag r a n u l o m a[ 1]. Chemokines play a key role
in controlling the migration of cell types found within the
lung during M. tuberculosis infection [2]. Chemokines are
divided into four subgroups on the basis of structural cri-
teria with the majority classes as CC or CXC chemokines [3].
CXC chemokines include CXCL-8 (interleukin-8), which is
a potent neutrophil, monocyte, and T-lymphocyte chemoat-
tractant [4, 5], and CXCL-10 (interferon-inducible protein-
10), which attracts T-lymphocytes [6] but not neutrophils.
These CXC chemokines are produced by inﬂammatory cells
such as monocytes/macrophages [7, 8] and by human ep-
ithelial cells [9, 10]a f t e re x p o s u r et oM. tuberculosis and M.
bovis.Releaseofchemokinesbyhumanepithelialcells,which
are considered the major cellular source of chemokines in
the lung [11], can be modulated by Th2-derived cytokines
[12]. Recent data have indicated increased production of
interleukin(IL)-4, a Th2 cytokine, by cells from patients with
tuberculosis [13]. In addition, active tuberculosis has been
associated with increased Th2 activity in vivo [14]. This is
in agreement with the observation that patients with tu-
berculosis have raised levels of IgE antibody [15]. Although
the Th2 cytokines have been demonstrated to downregulate
chemokine secretion in a number of cellular models [12, 16,
17], little is known about their eﬀects on chemokine release
in Mycobacterium bovis bacillus calmette-gu´ erin- (BCG-) in-
fected human epithelial cells. Since the M. bovis BCG strain
is the only vaccine currently available for protection against
tuberculosis [18], this study aimed to investigate the eﬀect of
IL-4 on M. bovis BCG-induced CXCL-8 and CXCL-10 secre-
tion and gene expression in human epithelial cells.2 Mediators of Inﬂammation
MATERIALS AND METHODS
Reagents
Recombinant human IL-4, antihuman IL-4, and isotype-
matched control antibody were purchased from Santa Cruz
Biotechnology, Inc (Santa Cruz, Calif, USA)
Mycobacterialcultures
Mycobacterium bovis (ATCC 35733) was obtained from the
American Type Culture Collection (Rockville, Md, USA). M.
bovis was grown at 37◦Ci nS a u t o nm e d i u mf o r2w e e k s .
Cultures were centrifuged at 800rpm for 10min and then
washed three times in medium. Mycobacteria were resus-
pended in medium and aliquots of the stock were kept at
−70◦C.
Epithelialcellculture
The human epithelial HEp-2 cell line was originally acquired
from the American Type Culture Collection (Rockville, Md,
USA). Cells were cultured in minimum essential medium
Eagle supplemented with 2mM of L-glutamine, 1mM of
sodium pyruvate, 0.1mM of nonessential amino acids, and
Earle’s BSS adjusted to contain 1.5g/l of sodium bicarbonate
and 10% heat-inactivated foetal bovine serum (Gibco-BRL,
Rockville, Md, USA). Cells were grown at 37◦Ci nah u m i d -
iﬁed 5% CO2 atmosphere. Cells were used at approximately
80%–90% conﬂuence before performing experiments. The
human alveolar epithelial A549 cell line was maintained in a
humidiﬁed 5% CO2 atmosphere in Dulbecco’s modiﬁed Ea-
gle’s medium.
TreatmentofepithelialcellswithIL-4
Cells (105/well) were preincubated in growth media or dif-
ferent concentrations of IL-4 for 2h before infection with M.
bovis using an opsonized bacteria-to-cell ratio of 5 : 1. IL-4
did not aﬀect cell viability at the concentrations used. Neu-
tralizing antibody to IL-4 was added to some cultures. Un-
stimulated cells,culturedin media alone,served asa negative
control. The culture medium for the detection of chemokine
release was harvested for analysis after 24h.
AssessmentofCXCL-8andCXCL-10mRNA
expressionbyRT-PCR
mRNAlevelswereassessedusingreversetranscription-(RT-)
PCR assay. In these experiments, HEp-2 cells were treated
with IL-4 (50ng/mL) for 2h, and were then infected with
M. bovis BCG at an MOI = 5. Total RNA from cells was
obtained using TRIzol reagent (Life Technologies, Rockville,
Md, USA) as per the manufacturer’s instructions. Cellular
RNA (1μg) was reverse transcribed to cDNA. The mRNA
of the chemokines CXCL-8 and CXCL-10 were analyzed
by PCR essentially as described [19]. To verify that equal
amounts of undegraded RNA was added in each RT-PCR re-
action, GAPDH was used as an internal standard. Ampliﬁed
PCR products were detected using 2% agarose ethidium bro-
mide gel electrophoresis and photographed.
QuantiﬁcationofCXCL-8andCXCL-10byELISA
The levels of immunoreactive CXCL-8 and CXCL-10 were
determined with cytokine-speciﬁc commercial ELISA kits
as per the manufacturer’s instructions (R&D Systems, Min-
neapolis, Minn, USA). The lower limit of sensitivity of the
CXCL-8 assay was 3pg/mL, and that of the CXCL-10 assay
was 11pg/mL.
Statistics
Data are presented as means from at least three separate ex-
periments with standard errors of the means (SEMs). Sta-
tistical signiﬁcance of diﬀerences was assessed by Student’s
t-test. The value of P ≤ .05 is taken as statistically signiﬁcant.
RESULTS
EffectofIL-4onM.bovisBCG-inducedCXCL-8and
CXCL-10geneexpression
WeﬁrstinvestigatedtheeﬀectofIL-4onCXCL-8andCXCL-
10 gene expression from human epithelial cells infected with
M. bovis BCG. To test this, HEp-2 cells were pretreated with
or without IL-4 and then infected with M. bovis BCG. After
incubation total RNA was isolated and the levels of CXCL-
8 mRNA or CXCL-10 mRNA were measured by RT-PCR
method. As shown in Figures 1(a) and 1(b),C X C L - 8m R N A
and CXCL-10 mRNA were expressed after infection with M.
bovis BCG, and IL-4 reduced gene expression of CXCL-8
in M. bovis BCG-infected HEp-2 cells (Figure 1(a))b u tn o t
CXCL-10 gene expression (Figure 1(b)). These results indi-
cate that inhibition of M. bovis BCG-induced expression of
CXCL-8 by IL-4 is a result of transcriptional downregulation
of CXCL-8.
DownregulationofCXCL-8secretionfromhuman
epithelialcellsinfectedwithM.bovisBCGbyIL-4
Recentworkin ourlaboratoryhasdemonstratedthat human
cells secrete CXCL-8 and CXCL-10 in response to M. bovis
BCG[19].Inthisstudy,weexaminedtheeﬀectofIL-4atvar-
iousconcentrationsonproductionofCXCL-8andCXCL-10.
HEp-2 cells were pretreated with increasing concentrations
of IL-4 and infected with M. bovis at MOI = 5. The data
in Figure 2(a) demonstrate that IL-4 signiﬁcantly suppressed
M.bovisBCG-inducedCXCL-8secretioninaconcentration-
dependent manner. Maximal inhibition in this series of ex-
periments was 62% when 2073±296pg/mL of CXCL-8 pro-
duction with M. bovis BCG was reduced to 788 ±128pg/mL
by IL-4 at 50ng/mL. In contrast, IL-4 at 50ng/mL enhanced
M. bovis BCG-induced CXCL-10 production to a small de-
gree (Figure 2(b)). To further evaluate the speciﬁcity of the
eﬀect of IL-4 on M. bovis BCG-induced CXCL-8 secretion,
diﬀerent concentrations of a neutralizing antibody to IL-4 orPatricia M´ endez-Samperio et al 3
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Figure 1: IL-4 has divergent eﬀects on M. bovis BCG-induced chemokine gene expression. HEp-2 cells were treated with IL-4 (50ng/mL)
prior to infection with M. bovis BCG. After incubation total RNA was isolated and the levels of (a) CXCL-8 mRNA or (b) CXCL-10 mRNA
were measured by RT-PCR method. PCR products were run on a 2% agarose gel containing ethidium bromide. The results depicted are
representative of three independent experiments. GAPDH, glyceraldehhyde 3-phosphato dehydrogene probe was used to conﬁrm equal
RNA loading. The histograms represent relative transcription rates, which were calculated after normalization to the respective GAPDH
signal.
an isotype-matched control antibody were added to HEp-2
cells treated with IL-4 (50ng/mL). As indicated in Figure 3,
inhibitionofM.bovisBCG-inducedCXCL-8secretionbyIL-
4 was signiﬁcantly suppressed with 10μg of anti-IL-4 anti-
body/mL. It is important to note that an isotype-matched
control antibody did not aﬀect the eﬀect of IL-4 on M. bovis
BCG-induced CXCL-8 secretion (Figure 3). Next, to conﬁrm
the regulatory eﬀect of IL-4 on M. bovis BCG-induced CXC
chemokine secretion, we also used the human alveolar ep-
ithelial A549 cell line. As shown in Figure 4, a similar eﬀect
of IL-4 on M. bovis BCG-induced CXCL-8 and CXCL-10 se-
cretion was observed by using other epithelial A549 cell line.
RegulationthatcorrelatedwiththeeﬀectofIL-4observedfor
the CXCL-8 and CXCL-10 mRNA gene expression.
DISCUSSION
Inﬂammation is a series of coordinated events that depend
on leukocyte recruitment to the site of inﬂammation, in
which chemokines play an important role [20, 21]. Our
present data demonstrate that the eﬀect of IL-4 on CXCL-
8 and CXCL-10 secretion in M. bovis BCG-infected human
epithelial cells is entirely distinct, since IL-4 decreased M.
bovis-induced CXCL-8 production but not CXCL-10 secre-
tion.Mycobacterial-inducedproductionofCXCL-8hasbeen
previously demonstrated in human alveolar macrophages,
in monocytic THP1 cells, and in bronchoalveolar lavage
of pleural ﬂuid from pulmonary tuberculosis patients [7–
10, 22]. However, the downregulation of CXCL-8 by IL-4
following M. bovis infection is a novel ﬁnding. Moreover,
further experiments were conducted to determine that the
mechanism by which this Th2-derived cytokine downreg-
ulates CXCL-8 secretion is mediated at the transcriptional
level. According to previous study [23], it has been demon-
strated that IL-4 had no eﬀect on TNF-α/IFN-γ-induced
CXCL-8expressionandsecretionbyepithelialcells.Suchdis-
cordance suggests that the mechanism by which IL-4 regu-
lates CXCL-8 secretion is stimulus-speciﬁc. In addition, our
results, indicating an important role for transcriptional ac-
tivation in epithelial cells in response to M. bovis BCG, are
in agreement with published data which have demonstrated
that the induction of chemokine secretion from epithelial
cells by mycobacteria occurs at the transcriptional level [24].
On the other hand, the observation that the production of
CXCL-10 was not aﬀected by the addition of IL-4 could be
ascribed to the activation of the NF-κB pathway induced by
the direct interaction of M. bovis with the human epithelial
cells,sinceithasbeendemonstratedthattheinfectionofcells
by mycobacteria stimulated a rapid binding of NF-κB to the
κBsitewithintheCXCL-10genepromoter[25].Theeﬀectof4 Mediators of Inﬂammation
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Figure 2: Eﬀect of recombinant IL-4 on M. bovis BCG-induced CXCL-8 and CXCL-10 secretion in HEp-2 cells. HEp-2 cells were cultured
without a stimulus (no stimuli) or infected by M. bovis BCG (5 : 1bacteria/cell) after 2h pretreatment with IL-4 (1–50ng/mL). The (a)
CXCL-8 and (b) CXCL-10 protein levels from cellular supernatants were measured by ELISA. Data are presented as mean ± SEM of ﬁve
independent experiments. Reduction of M. bovis BCG-induced CXCL-8 secretion after addition of 30 or 50ng IL-4 is statistically signiﬁcant
(∗P<. 01).
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Figure 3: Neutralizing anti-IL-4 antibody signiﬁcantly reverses the inhibitory eﬀe c to fI L - 4o nM. bovis BCG-induced CXCL-8 secretion.
HEp-2 cells were pretreated with IL-4 (50ng/mL) in the presence of diﬀerent concentrations of anti-IL-4 or an isotype control antibody for
2h prior to M. bovis infection for an additional 24h at 37◦C. CXCL-8 levels were measured by ELISA. The results are the means ± SEM for
four separate experiments.Patricia M´ endez-Samperio et al 5
0
4
8
12
16
20
24
×102
C
X
C
L
-
8
(
p
g
/
m
l
)
No stimuli
M. bovis
0 5 20 30 50
Concentration of IL-4 (ng/ml)
(32 %)
(47 %)
(a)
0
4
8
12
16
20
24
×103
C
X
C
L
-
1
0
(
p
g
/
m
l
)
No stimuli
M. bovis
0 5 20 30 50
Concentration of IL-4 (ng/ml)
(b)
Figure 4: Eﬀect of recombinant IL-4 on CXC chemokine secretion by human alveolar epithelial A549 cells infected with M. bovis BCG.
Cells were treated with medium (no stimuli) or increasing doses of IL-4 for 2h prior to infection with M. bovis BCG (MOI = 5). After 24h
incubation, supernatants was collected and (a) CXCL-8 or (b) CXCL-10 were measured by ELISA. Data shown are the mean ± SD of four
independent experiments. The percentage in parentheses indicates inhibition in the presence of IL-4 compared with M. bovis BCG cultures
which did not receive IL-4.
IL-4ontranscriptionfactoractivationandtheCXCL-10pro-
moter binding as well as on mRNA stability requires further
investigation.
Our results are in agreement with the hypothesis that
progressive tuberculosis disease might not be due to ab-
sence of Th1 response, but rather to the eﬀect of an un-
usual Th2 response [14]. Recently, it has been demonstrated
that progressive tuberculosis disease might be due to preex-
isting Th2-like activity by inducing toxicity of tumor necro-
sis factor-α and/or impair bactericidal function [26], we for
the ﬁrst time have demonstrated the selectively eﬀect of IL-
4 on chemokine release in M. bovis BCG-infected epithelial
cells, indicating a novel mechanism of the association of type
2 cytokines with mycobacterial infection. Downregulation of
CXCL-8secretionbyIL-4islikelytobeimportantduring the
human immune response to M. bovis infection, since it pro-
videsanopposingTh2-cellmechanisminvolvedinprotective
host immunity and neutrophil and T-lymphocyte migration
can be aﬀected by the reduction in CXCL-8, thus reducing
the cell-mediated response.
Of the Th2 cytokines, previous studies have demon-
stratedthatIL-13,whichlikeIL-4,isincreasedapproximately
100-fold compared to controls matched for age and gender
[27]. In view of the importance of IL-13, or of the shared
receptor between IL-4 and IL-13, our data do not allow us
to exclude the possibility that IL-4 synergizes with IL-13 to
downregulate CXCL-8 production during infection with M.
bovis BCG. We are currently investigating this possibility.
In summary, the data from this study demonstrate that
in M. bovis BCG-infected human epithelial cells IL-4 plays
an important role in downregulating CXCL-8 release. Fur-
ther experimental work is needed to know whether the eﬀect
ofIL-4onM.bovisBCG-inducedCXCL-8secretionmayrep-
resent a signiﬁcant regulatory mechanism in vivo. However,
these data may represent an important regulatory mecha-
nism during the immune response to M. bovis BCG, since
CXCL-8 induction during mycobacterial infection is a major
neutrophil-activating factor and chemotactic.
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